Deina H. Walsh's most recent trade in Bone Biologics Corp was a trade of 27,055 Employee Stock Option done . Disclosure was reported to the exchange on Jan. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bone Biologics Corp | Deina H. Walsh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 27,055 | 27,055 | - | - | Employee Stock Option | |
| Bone Biologics Corp | H. Walsh Deina | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 12,500 | 12,500 | - | - | Employee Stock Option | |
| Bone Biologics Corp | Deina H. Walsh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 18,875 | 43,875 | - | - | Employee Stock Option | |
| Bone Biologics Corp | Deina H. Walsh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 25,000 | 25,000 | - | - | Employee Stock Option |